全文获取类型
收费全文 | 41758篇 |
免费 | 2007篇 |
国内免费 | 177篇 |
专业分类
耳鼻咽喉 | 695篇 |
儿科学 | 725篇 |
妇产科学 | 771篇 |
基础医学 | 5447篇 |
口腔科学 | 1284篇 |
临床医学 | 2919篇 |
内科学 | 9674篇 |
皮肤病学 | 601篇 |
神经病学 | 3553篇 |
特种医学 | 1424篇 |
外科学 | 7166篇 |
综合类 | 170篇 |
一般理论 | 2篇 |
预防医学 | 1509篇 |
眼科学 | 722篇 |
药学 | 3553篇 |
中国医学 | 85篇 |
肿瘤学 | 3642篇 |
出版年
2021年 | 591篇 |
2020年 | 378篇 |
2019年 | 523篇 |
2018年 | 652篇 |
2017年 | 498篇 |
2016年 | 601篇 |
2015年 | 651篇 |
2014年 | 853篇 |
2013年 | 1117篇 |
2012年 | 1802篇 |
2011年 | 1940篇 |
2010年 | 1126篇 |
2009年 | 947篇 |
2008年 | 1817篇 |
2007年 | 1987篇 |
2006年 | 1946篇 |
2005年 | 1887篇 |
2004年 | 1838篇 |
2003年 | 1887篇 |
2002年 | 1813篇 |
2001年 | 1625篇 |
2000年 | 1774篇 |
1999年 | 1488篇 |
1998年 | 438篇 |
1997年 | 353篇 |
1996年 | 321篇 |
1995年 | 302篇 |
1994年 | 286篇 |
1993年 | 254篇 |
1992年 | 1103篇 |
1991年 | 922篇 |
1990年 | 899篇 |
1989年 | 938篇 |
1988年 | 834篇 |
1987年 | 831篇 |
1986年 | 779篇 |
1985年 | 772篇 |
1984年 | 528篇 |
1983年 | 424篇 |
1982年 | 218篇 |
1979年 | 482篇 |
1978年 | 274篇 |
1977年 | 251篇 |
1975年 | 207篇 |
1974年 | 223篇 |
1973年 | 203篇 |
1972年 | 205篇 |
1971年 | 231篇 |
1969年 | 231篇 |
1968年 | 216篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Shimon Kurasawa Takahiro Imaizumi Shoichi Maruyama Keitaro Tanaka Yoko Kubo Mako Nagayoshi Hiroaki Ikezaki Sadao Suzuki Teruhide Koyama Chihaya Koriyama Aya Kadota Sakurako Katsuura-Kamano Kiyonori Kuriki Kenji Wakai Keitaro Matsuo 《International journal of cancer. Journal international du cancer》2023,153(4):732-741
The association between kidney function and cancer incidence is inconsistent among previous reports, and data on the Japanese population are lacking. It is unknown whether kidney function modifies the cancer risk of other factors. We aimed to evaluate the association of estimated glomerular filtration rate (eGFR) with cancer incidence and mortality in 55 242 participants (median age, 57 years; 55% women) from the Japan Multi-Institutional Collaborative Cohort Study. We also investigated differences in cancer risk factors between individuals with and without kidney dysfunction. During a median 9.3-year follow-up period, 4278 (7.7%) subjects developed cancer. Moderately low and high eGFRs were associated with higher cancer incidence; compared with eGFR of 60-74 ml/min/1.73 m2, the adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) for eGFRs of ≥90, 75-89, 45-59, 30-44 and 10-29 ml/min/1.73 m2 were 1.18 (1.07-1.29), 1.09 (1.01-1.17), 0.93 (0.83-1.04), 1.36 (1.00-1.84) and 1.12 (0.55-2.26), respectively. High eGFR was associated with higher cancer mortality, while low eGFR was not; the adjusted subdistribution HRs (95% CIs) for eGFRs of ≥90 and 75-89 ml/min/1.73 m2 were 1.58 (1.29-1.94) and 1.27 (1.08-1.50), respectively. Subgroup analyses of participants with eGFRs ≥60 and <60 ml/min/1.73 m2 revealed elevated cancer risks of smoking and family history of cancer in those with eGFR <60 ml/min/1.73 m2, with significant interactions. Our findings suggest that the relationship between eGFR and cancer incidence was U-shaped. Only high eGFR was associated with cancer mortality. Kidney dysfunction enhanced cancer risk from smoking. 相似文献
3.
Hiroyuki Kawano Yuko Honda Tatsuo Amano Haruko Okano Rieko Suzuki Masataka Torii Yoshiko Unno Yoshiaki Shiokawa Teruyuki Hirano 《Journal of stroke and cerebrovascular diseases》2019,28(2):399-404
Background
Anticoagulation therapy, particularly subcutaneous heparin therapy, is recommended for cancer-associated thrombosis. However, not starting or discontinuing anticoagulation was not rare. The aim of the present study was to examine the practical issues related to anticoagulation therapy and effects of subcutaneous heparin therapy for cancer-associated stroke.Methods
Patients with cancer-associated stroke in our stroke center between October 2014 and August 2017 who were diagnosed as having acute ischemic stroke based on diffusion-weighted imaging were retrospectively enrolled. Baseline clinical characteristics, heparin injection, reasons for no subcutaneous heparin therapy, and clinical outcomes were collected.Results
A total of 59 patients with cancer-associated stroke (75 ± 10 years old, male 42%) were enrolled. Lung cancer was the most frequently observed cancer (n = 17, 29%), followed by gastric cancer (n = 8, 14%) and pancreatic cancer (n = 8, 14%). Of the 19 patients (32%) who underwent subcutaneous heparin therapy, it was discontinued in 9 (47%), mainly because of patients’ medical conditions (deterioration of cancer or hemorrhagic complication). Ten patients with long-term subcutaneous heparin therapy did not have stroke recurrence. In contrast, among nine patients who discontinued subcutaneous heparin therapy, three (33%) had recurrence of ischemic stroke. Of the 40 patients without subcutaneous heparin therapy, the main reasons for no subcutaneous heparin therapy were the patients’ medical conditions (n = 22, 55%).Conclusions
Although subcutaneous heparin therapy was given to only one third of cancer-associated stroke patients, long-term subcutaneous heparin therapy might prevent recurrence of cancer-associated stroke. 相似文献4.
5.
Maki Namura Hiroko Tsunoda Daiki Kobayashi Katsutoshi Enokido Atsushi Yoshida Tadashi Watanabe Koyu Suzuki Seigo Nakamura Hideko Yamauchi Naoki Hayashi 《Clinical breast cancer》2019,19(4):278-285
BackgroundAxillary lymph node (LN) dissection after neoadjuvant chemotherapy (NAC) still remains a standard treatment of initially LN-positive primary breast cancer because of the difficulty of assessment of LN status. The aim of this study was to assess the LN status after NAC in initially LN-positive primary breast cancer patients who were assessed as clinically LN-negative after NAC (ycN0) and identify factors associated with loss of LN metastasis.Patients and MethodsThe study cohort comprised 279 patients with cytology-proven LN-positivity before NAC. LN status was assessed by ultrasonography. Regional recurrence-free survival and overall survival according to pathologic LN after NAC (ypN) status were assessed in patients with ycN0.ResultsOf the 279 patients, 179 patients (64.2%) had ycN0. High nuclear grade, estrogen receptor-negative (ER?), and human epidermal growth factor receptor 2-positive (HER2+), were significant predictors of ycN0/ypN0 (P < .001, .007, and .046, respectively). Metastases persisted in 1 or 2 LNs for 5 (20.0%) of 25 patients with ER?/HER2+ and for 4 (21.1%) of 19 patients with ER?/HER2?, and in 3 or more LNs for 0 (0%) of 25 patients with ER?/HER2+ and for 1 (5.3%) of 19 patients with ER?/HER2?. Patients with ER+ tumors had more numerous residual LN metastases than those with ER? tumors (P < .001). Among patients with ycN0, ypN status was not associated with regional recurrence-free survival or overall survival.ConclusionsThree or more residual LN metastases were rare in patients with ER? tumors if assessed as ycN0 by ultrasonography. Prospective studies are needed to confirm the prognostic impact of not performing axillary lymph node dissection in such patients. 相似文献
6.
Suzuki Satoshi Kanaji Shingo Yamamoto Masashi Oshikiri Taro Nakamura Tetsu Kakeji Yoshihiro 《World journal of surgery》2019,43(4):1076-1084
World Journal of Surgery - Preoperative nutritional status is considered to affect the short-term and long-term outcomes of cancer patients. The clinical value of the controlling nutritional status... 相似文献
7.
8.
Yoshihiro Goto Takahiro Suzuki Yoko Suzuki Kazushi Anzawa Takashi Mochizuki Takashi Tamura Koichi Makimura Masahiro Aoshima Taisuke Ito Yoshiki Tokura 《The Journal of dermatology》2019,46(9):794-797
We report a case of kerion celsi due to Trichophyton tonsurans. An 18‐year‐old male student judo practitioner had alopecic patches, black dots and subcutaneous abscesses on the right temporal region. The damaged hair represented endothrix infection with T. tonsurans, as assessed by mycological examinations. He was treated with oral itraconazole without any therapeutic effect, followed by terbinafine with good effect. A skin biopsy showed neutrophil, lymphocyte and histiocyte infiltration into the dermis and subcutaneous tissue with abscesses around a number of dilated hair follicles. Immunostaining showed that the expression level of human β‐defensin 2 (HBD‐2) was decreased in the epidermis of the alopecic and adjacent skin. Because interleukin (IL)‐17A generally induces HBD‐2 production by epidermal keratinocytes, we also immunohistochemically investigated IL‐17A expression. Unexpectedly, many IL‐17A‐bearing cells were found around destructed hair follicles, indicating that IL‐17A expression was not attenuated, but rather increased in the skin lesion. Our case suggests that IL‐17A‐upregulated antimicrobial peptide expression is disordered in kerion celsi, and severe inflammation with IL‐17A may cause tissue damage and resultant scar. 相似文献
9.
Hideki Kobara Hirohito Mori Noriko Nishiyama Shintaro Fujihara Keiichi Okano Yasuyuki Suzuki Tsutomu Masaki 《Journal of gastroenterology and hepatology》2019,34(1):22-30
Rescue therapy for gastrointestinal (GI) refractory bleeding, perforation, and fistula has traditionally required surgical interventions owing to the limited performance of conventional endoscopic instruments and techniques. An innovative clipping system, the over‐the‐scope clip (OTSC), may play an important role in rescue therapy. This innovative device is proposed as the final option in endoscopic treatment. The device presents several advantages including having a powerful sewing force for closure of GI defects using a simple mechanism and also having an innovative feature, whereby a large defect and fistula can be sealed using accessory forceps. Consequently, it is able to provide outstanding clinical effects for rescue therapy. This review clarifies the current status and limitations of OTSC according to different indications of GI refractory disease, including refractory bleeding, perforation, fistula, and anastomotic dehiscence. An extensive literature search identified studies reported 10 or more cases in which the OTSC system was applied. A total of 1517 cases described in 30 articles between 2010 and 2018 were retrieved. The clinical success rates and complications were calculated overall and for each indication. The average clinical success rate was 78% (n = 1517) overall, 85% for bleeding (n = 559), 85% (n = 351) for perforation, 52% (n = 388) for fistula, 66% (n = 97) for anastomotic dehiscence, and 95% (n = 122) for other conditions, respectively. The overall and severe OTSC‐associated complications were 1.7% (n = 23) and 0.59% (n = 9), respectively. This review concludes that the OTSC system may serve as a safe and productive device for GI refractory diseases, albeit with limited success for fistula. 相似文献
10.